Access

Letters to Editor


Nature Medicine 8, 1186 - 1188 (2002)
doi:10.1038/nm1102-1186



There is a Corrigendum (April 2004) associated with this Letters to Editor.

Hypothalamic gray matter changes in narcoleptic patients

B. Draganski1, P. Geisler2, G. Hajak2, G. Schuierer3, U. Bogdahn1, J. Winkler1 & A. May1

  1. Department of Neurology, University of Regensburg, Regensburg, Germany
  2. Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany
  3. Institute of Neuroradiology, University of Regensburg, Regensburg, Germany

Correspondence to: A. May1 e-mail: arne.may@klinik.uni-regensburg.de

Narcolepsy, a chronic sleep disorder, is characterized by excessive daytime sleepiness, disturbed nocturnal sleep, cataplexy (sudden loss of muscle tone) and various symptoms associated with abnormal rapid-eye movement (REM) sleep, including hypnagogic hallucinations and sleep paralysis. Emotions or provocative circumstances can modulate the pattern and severity of clinical appearance.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Sleep Disorders
Nature Encyclopaedia of Life Sciences

REVIEWS
THE HYPOCRETINS: SETTING THE AROUSAL THRESHOLD
Nature Reviews Neuroscience Review Article (01 May 2002)
 See all 4 matches for Reviews

NEWS AND VIEWS
Orchestrating sleep-wake functions in the brain
Nature Medicine News and Views (01 Feb 2003)

RESEARCH
Sulpiride, a D2/D3 Blocker, Reduces Cataplexy but not REM Sleep in Canine Narcolepsy
Neuropsychopharmacology Original Article (01 Nov 2000)
MAO-A and COMT polymorphisms and gene effects in narcolepsy
Molecular Psychiatry Communications (01 Jun 2001)
 See all 9 matches for Research